Presentation by Kevin Garey, PharmD, MS, FIDSA, Professor and Chair, University of Houston College of Pharmacy, at ESCMID (April 2024) entitled “ Efficacy and safety of ibezapolstat compared with vancomycin for the treatment of Clostridioides difficile infection: a phase 2, randomized, double-blind study
Golf Coast Consortia AMR Conference Presentation of Ph2b Comparative Microbiology and Microbiome Data, by Dr. Kevin Garey, et. al., January 2024
ID Week Presentation Dr. Kevin Garey “Gram Positive Selective Spectrum Activity of Ibezapolstat October 2023
Poster Presentation (ECCMID) April 2023 by Dr. Kevin Garey titled “Novel pharmacology and susceptibility of ibezapolstat against Clostridioides Difficile isolates with reduced susceptibility to C difficile directed antibiotics
ID Week Presentation (October 2022) Development Update on Ibezapolstat for the Treatment of Clostridioides difficile infection: Focus on the Microbiome
